SEC Filing Details

Document Details

Filing Date
Dec 23, 2010
Document Date
Sep 30, 2010
Form Description
Amendment to a previously filed 10-Q
Filing Group
Quarterly Filings
Company
Celldex Therapeutics
Issuer
CELLDEX THERAPEUTICS, INC.

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline